Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Fresh Tracks Therapeutics Inc > Condensate $68 Can now
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(185)
•••
Comment by Bennys65on Jan 10, 2021 11:14am
217 Views
Post# 32263108

RE:RE:RE:RE:RE:RE:RE:Condensate $68 Can now

RE:RE:RE:RE:RE:RE:RE:Condensate $68 Can nowMaybe so John but he is on the board giving him the inside track on what the Riverstone GMT guys are thinking.If a lowball takeout was on the table dont think he would be such a large holder of Pipe stock.Anyway glad we agree on the quality of our management.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities